SureTrader
Interactive Brokers Advertisement
SureTrader
Home > Boards > US Listed > Biotechs > Compugen (CGEN)

6:01AM Compugen announces results showing its CGEN-15001T drug

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 418
Posts 22,593
Boards Moderated 3
Alias Born 09/11/06
160x600 placeholder
Compugen Presents at ASCO COM701 Drug Combination Data with TIGIT and PD-1 Inhibitors in Preclinical Models "PR Newswire (US)" - 6/5/2017 9:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/31/2017 7:01:11 AM
Compugen Provides Update on COM701 and Upcoming Presentations "PR Newswire (US)" - 5/31/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/30/2017 6:21:35 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/25/2017 7:31:09 AM
Compugen Announces Appointment of Dr. Michal Preminger to Board of Directors "PR Newswire (US)" - 5/25/2017 7:06:00 AM
Compugen to Present at Two Upcoming Investor Conferences in June "PR Newswire (US)" - 5/23/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/9/2017 8:01:21 AM
Compugen Reports First Quarter 2017 Results "PR Newswire (US)" - 5/9/2017 7:13:00 AM
Compugen First Quarter 2017 Conference Call Scheduled for Tuesday, May 9, 2017 at 10:00 AM ET "PR Newswire (US)" - 4/26/2017 7:00:00 AM
Compugen Announces Lead Therapeutic Candidate COM902 for CGEN-15137/TIGIT Immuno-Oncology Program "PR Newswire (US)" - 3/28/2017 7:14:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 3/28/2017 7:04:24 AM
Compugen to Present CGEN-15001 Autoimmune Product Candidate at Upcoming Conferences "PR Newswire (US)" - 3/22/2017 7:00:00 AM
Compugen Announces Addition of Prof. Miriam Merad to Its Scientific Advisory Board "PR Newswire (US)" - 3/8/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 2/15/2017 7:31:55 AM
Compugen Reports Fourth Quarter and Calendar Year 2016 Results "PR Newswire (US)" - 2/15/2017 7:20:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/14/2017 5:05:13 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/1/2017 5:07:23 PM
Compugen Fourth Quarter and Yearend 2016 Conference Call Scheduled for Wednesday, February 15, 2017 at 10:00 AM EST "PR Newswire (US)" - 1/30/2017 7:00:00 AM
Compugen's CGEN-15001 Demonstrates Restoration of Immune Tolerance in Autoimmunity "PR Newswire (US)" - 1/4/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/8/2016 6:07:36 AM
Compugen Announces Key Highlights from R&D Day "PR Newswire (US)" - 12/7/2016 11:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/7/2016 8:01:46 AM
Compugen Discloses its Cancer Immunotherapy Program Targeting TIGIT Immune Checkpoint "PR Newswire (US)" - 12/7/2016 7:22:00 AM
Compugen Appoints Senior Vice President Corporate and Business Development "PR Newswire (US)" - 12/5/2016 7:00:00 AM
surf1944   Thursday, 02/02/12 10:57:15 AM
Re: surf1944 post# 109
Post # of 157 
6:01AM Compugen announces results showing its CGEN-15001T drug may have potential for cancer immunotherapy (CGEN) 5.30 : Co announced results demonstrating the therapeutic potential of CGEN-15001T as a drug target for treatment of multiple cancers by means of monoclonal antibody ("mAb") therapy. These results indicate that CGEN-15001T is expressed on numerous types of cancer, such as carcinomas, sarcomas, melanoma and hematological cancers as well as on immune cells. These findings, together with previous results supporting its active immunomodulatory effect, 'strongly support CGEN-15001T's potential as a powerful drug target for treatment of various solid and hematological cancers, an area of great interest to the pharmaceutical industry.'


surf's up......crikey



SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist